The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs

JE Kipp - International journal of pharmaceutics, 2004 - Elsevier
Water insolubility has always been a key obstacle in pharmaceutical formulation, affecting
formulation stability and drug bioavailability. Approaches for achieving complete dissolution …

Application of nanoparticles in oral delivery of immediate release formulations

F Kesisoglou, S Panmai, Y Wu - Current Nanoscience, 2007 - ingentaconnect.com
An increasing percentage of drug development candidates suffer from poor aqueous
solubility which in turn often times leads to poor oral absorption. This poses significant …

Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future

RH Müller, C Jacobs, O Kayser - Advanced drug delivery reviews, 2001 - Elsevier
An increasing number of newly developed drugs are poorly soluble; in many cases drugs
are poorly soluble in both aqueous and organic media excluding the traditional approaches …

Drug delivery strategies for poorly water-soluble drugs: the industrial perspective

P van Hoogevest, X Liu, A Fahr - Expert opinion on drug delivery, 2011 - Taylor & Francis
Introduction: For poorly soluble compounds, a good bioavailability is typically needed to
assess the therapeutic index and the suitability of the compound for technical development …

Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right?

SA Abouelmagd, B Sun, AC Chang, YJ Ku… - Molecular …, 2015 - ACS Publications
In vitro drug release kinetics studies are routinely performed to examine the ability of new
drug formulations to modulate drug release. The underlying assumption is that the studies …

Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs

T Vasconcelos, B Sarmento, P Costa - Drug discovery today, 2007 - Elsevier
Solid dispersions are one of the most promising strategies to improve the oral bioavailability
of poorly water soluble drugs. By reducing drug particle size to the absolute minimum, and …

Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs

J Hu, KP Johnston, RO Williams III - Drug development and …, 2004 - Taylor & Francis
Poor water solubility is an industry wide issue, especially for pharmaceutical scientists in
drug discovery and drug development. In recent years, nanoparticle engineering processes …

Nanoparticles: a personal experience for formulating poorly water soluble drugs

ER Cooper - Journal of Controlled Release, 2010 - Elsevier
This short paper is a personal account of the development of techniques to enhance the
bioavailability of a series of poorly soluble drugs by particle size reduction to the nanometer …

[PDF][PDF] Solid dispersions: an overview to modify bioavailability of poorly water soluble drugs

R Tiwari, G Tiwari, B Srivastava… - International Journal of …, 2009 - academia.edu
An ideal drug delivery system should be able to deliver an adequate amount of drug,
preferably for an extended period of time for its optimum therapeutic activity. Most drugs are …

Overcoming poor oral bioavailability using nanoparticle formulations–opportunities and limitations

PP Desai, AA Date, VB Patravale - Drug Discovery Today: Technologies, 2012 - Elsevier
Oral delivery of drugs with poor aqueous solubility and poor enzymatic and/or metabolic
stability is very challenging. However, the advent of nanotechnology has revolutionized the …